§ EQUITY
USDBRNS
BARINTHUS BIOTHERAPEUTICS PL
USD
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
5 increased/new, 2 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| M&G PLC | 5.2M | 0.0% | ±0% |
| HSG Holding Ltd | 1.4M | 0.1% | ±0% |
| GLR Partners, LLC | 1.2M | 0.4% | n/a |
| DC Funds, LP | 642K | 24.6% | ±0% |
| Rangeley Capital, LLC | 159K | 0.1% | +89% |
| Renaissance Technologies | 151K | 0.0% | +6% |
◇ AC INTELLIGENCE
Top institutional owners for BRNS as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER96.0% · 8 holders
SYSTEMATIC / QUANT1.6% · 1 holder
TACTICAL / MACRO1.3% · 1 holder
DEALER / BANK0.8% · 2 holders
PASSIVE / INDEX0.3% · 2 holders
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for BRNS in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention BRNS yet.